George Perry (University of Texas at San Antonio [UTSA], San Antonio, TX), a valued member of our editorial board for US Neurology, discusses therapeutic targets in Alzheimer’s disease with a particular focus on the role of oxidative stress in the underlying pathophysiology of the disease.
1. Why do you think so many Alzheimer’s disease (AD) therapies have failed in phase III clinical studies? (0:09)
2. What are the most promising alternative therapeutic targets under investigation? (0:54)
3. What is the role of oxidative stress in the pathophysiology of AD? (1:49)
4. What is the main intracellular source of oxidative stress in AD? (2:36)
5. How can oxidative stress and mitochondria be targeted therapeutically? (3:17)
Speaker disclosure: George Perry serves as an advisor for Investicure and Phoenix Biotech, and is a board member for Neurotez and Neurotrope.
Filmed during a video call with Editorial Board member George Perry from his office at the University of Texas at San Antonio (UTSA), San Antonio, TX, US, July 2018.
Share this Video
Related Videos In Alzheimer's Disease & Dementia
Marwan Sabbagh: Approval of Aducanumab for Alzheimer’s Disease
It was a great pleasure to meet up with Marwan Sabbagh (Cleveland Clinic Lerner College of Medicine, Las Vegas, NV, USA), to discuss the recent approval of aducanumab for Alzheimer’s Disease. Aducanumab was granted accelerated approval on June 7 2021, by the U.S. Food and Drug Administration (FDA). Questions: Could you give us a brief […]
Claudia Trenkwalder, EAN 2021: REM Sleep Behaviour Disorder and Neurodegeneration
touchNEUROLOGY was joined by Prof. Claudia Trenkwalder (Paracelsus-Elena-Hospital, Kassel Germany, University Medical Center, Goettingen, Germany) to discuss her EAN presentation looking into REM Sleep Behaviour Disorder and the connection with neurodegeneration. The abstract entitled: ‘REM Sleep Behaviour Disorder (RBD): future implications for neurodegenerative disease’ was presented at the 7th Congress of the European Academy of […]
Ivana Rosenzweig, Sleep and Breathing 2021: The Link Between Sleep Apnoea and Dementia
We were delighted to speak with Dr Ivana Rosenzweig (Sleep and Brain Plasticity Centre, King’s College London, London, UK) around her talk on the ‘Link between sleep apnoea and dementia: the neuroimaging perspective‘, which was presented at the virtual 2021 Sleep and Breathing Conference, 16-17 April, 2021. Questions What is known about the relationship between […]
Journal articles and more to your inbox
Get the latest clinical insights from touchNEUROLOGYSign me up!